About FinOrion Pharma
FinOrion Pharma is a Healthcare company based in India. Pharmaceutical development, manufacturing, and supply chain management in India. It operates in the Healthcare and Transportation, Automotive & Logistics sectors. The company has 149 employees. Its Indian entity Finorion Pharma India Private Limited reported revenue of ₹38.28 Cr. FinOrion Pharma offers products and services including Human Pharmaceuticals and Veterinary Pharmaceuticals. Its focus areas include Pharmaceuticals, Drug Development, Human and Veterinary Drugs and Supply Chain.
Company details
FinOrion Pharma is operated as the India subsidiary of Orion, a Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals along with active ingredients. Established in Mumbai in 2008, it is utilized to enhance business relationships and support global operations, primarily through Supply Chain and Product Lifecycle Management activities. The companys people are recognized as key assets, with their skills driving excellence in a collaborative environment. Sustainability efforts are integrated to minimize environmental impact while promoting well-being for individuals, animals, and society, as validated by certifications like Great Place to Work.
- Headquarters India
- Employees 149
- SectorsHealthcareTransportation, Automotive & Logistics
- Email••••••••
- Website orionpharma.in
- Social LinkedIn
- Legal Name Finorion Pharma India Private Limited
- Date of Incorporation 23 Dec, 2011
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹38.28 Cr
FY 2025 · +8% YoY
- Net Profit₹4.61 Cr
FY 2025 · 12% margin
- EBITDA₹6.71 Cr
FY 2025 · 18% margin
- Employee Count149
Associated legal entities of FinOrion Pharma
FinOrion Pharma operates through Finorion Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Finorion Pharma India Private Limited CIN U74120MH2011PTC225361 | Active | 23 Dec 2011 | Mumbai, Maharashtra | ₹38.3 Cr | 149 | 6 | View details |
Products & Services of FinOrion Pharma
FinOrion Pharma offers a comprehensive portfolio of products and services, including Human Pharmaceuticals and Veterinary Pharmaceuticals.
Human pharmaceuticals are developed and manufactured for health purposes
Veterinary pharmaceuticals are produced and marketed for animal well-being
Board of directors of Finorion Pharma India Private Limited (FinOrion Pharma)
Finorion Pharma India Private Limited is the primary company behind FinOrion Pharma. The board of Finorion Pharma India Private Limited currently have 6 directors; the longest-serving is Olli Heikki Huotari, appointed in 2011. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Olli Heikki Huotari DIN 05119036 | Director | 23 Dec 2011 | 14 yrs 10 mo | Finorion Pharma India Private Limited |
| Johanna Linnea Pakkanen DIN 07320123 | Director | 24 Nov 2015 | 10 yrs 11 mo | Finorion Pharma India Private Limited |
| Samrudhi Mangesh Utturkar DIN 08162610 | Director | 29 May 2018 | 8 yrs 5 mo | Finorion Pharma India Private Limited |
| Rene Kristian Lindell DIN 10717452 | Director | 05 Aug 2024 | 2 yrs 3 mo | Finorion Pharma India Private Limited |
| Mikko Tapani Kemppainen DIN 11046428 | Director | 24 Apr 2025 | 1 yr 6 mo | Finorion Pharma India Private Limited |
| Pekka Juhani Kankaanpaa DIN 11048805 | Director | 24 Apr 2025 | 1 yr 6 mo | Finorion Pharma India Private Limited |
People of FinOrion Pharma
1 people are tracked at FinOrion Pharma (1 in leadership); the tracked headcount is 149.
| Name | Role | Group |
|---|---|---|
| Country Director | Leadership |
Complete people profiles for FinOrion Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of FinOrion Pharma
Figures of Finorion Pharma India Private Limited, the primary company behind FinOrion Pharma, for FY 2025. Revenue was ₹38.28 Cr (+8% year on year). Net profit was ₹4.61 Cr (12% margin). EBITDA was ₹6.71 Cr (18% margin). Revenue has grown at a compounded annual rate of +14% over three years and +9% over five years.
- ₹38.28 CrRevenue · FY 2025 · +8% YoY
- ₹4.61 CrNet profit · 12% margin
- ₹6.71 CrEBITDA · 18% margin
- ₹5 LakhPaid-up capital
- 149Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Finorion Pharma India Private Limited are on its company page.
Detailed financial statements for FinOrion Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Finorion Pharma
Complete news archive for FinOrion Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FinOrion Pharma
FinOrion Pharma is headquartered in India.
FinOrion Pharma has 149 employees.
The primary company behind FinOrion Pharma, Finorion Pharma India Private Limited, reported revenue of ₹38.28 Cr for FY 2025, up 8% year on year.
FinOrion Pharma is operated as the India subsidiary of Orion, a Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals along with active ingredients. Established in Mumbai in 2008, it is utilized to enhance business relationships and support global operations, primarily through Supply Chain and Product Lifecycle Management activities. The companys people are recognized as key assets, with their skills driving excellence in a collaborative environment. Sustainability efforts are integrated to minimize environmental impact while promoting well-being for individuals, animals, and society, as validated by certifications like Great Place to Work.
FinOrion Pharma offers Human Pharmaceuticals and Veterinary Pharmaceuticals.
FinOrion Pharma operates through Finorion Pharma India Private Limited.
The legal entities of FinOrion Pharma currently have 6 directors, including Olli Heikki Huotari, Samrudhi Mangesh Utturkar, Rene Kristian Lindell and others.